Sorafenib Dose Escalation in Renal Cell Carcinoma

Clinical trial NCT00618982 · COMPLETED

Trial details

NCT number: NCT00618982
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Renal Cell

Start date: 2008-02-01
Primary completion: 2009-04-01
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.